Skip to content

The Influence of Leg Elevation on Noradrenaline Requirements During Cesarean Delivery

The Influence of Thirty-degree Leg Elevation on Noradrenaline Requirements Administered as a Prophylactic Variable Infusion During Cesarean Delivery: An Open Label Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06822699
Enrollment
80
Registered
2025-02-12
Start date
2025-03-14
Completion date
2025-05-08
Last updated
2025-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Hypotension, Hypoperfusion

Brief summary

Spinal anesthesia is a widely chosen technique in obstetric theaters due to several advantages, however sympathetic block results in hypotension that carry several consequences on maternal and fetal health, thus early prediction and management takes high priority. in this regards recent recommendations suggest the use of prophylactic vasopressors like noradrenaline, researchers of this study aimed to explore the impact of leg elevation on prophylactic noradrenaline dose

Detailed description

after spinal anesthesia, patients will be randomly allocated into 2 groups : Leg elevation group and control group. noradrenaline will be used as variable infusion starting from 0.05 microgram/kg/min up to 0.14 microgram /kg/minute. noradrenaline infusion will be continued till delivery of the baby

Interventions

leg will be raised 30 degrees after spinal anesthesia using standardized pillow

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* full term * singleton pregnancy * ASA II

Exclusion criteria

* decline to participate * baseline SBP \<100 mmHg * failed spinal anesthesia * allergy to local anesthetic * coagulopathy

Design outcomes

Primary

MeasureTime frameDescription
Average noradrenaline requirementsbaseline to delivery of the babyaverage noradrenaline requirements in both groups (mcg/kg/min)

Secondary

MeasureTime frame
Total noradrenaline requirementsbaseline to delivery
incidence of spinal hypotensionbaseline to delivery
incidence of severe hypotensionbaseline to delivery

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026